New test to detect coronavirus; US FDA approves Breathalyzer Test for Covid-19

The first breath test to detect the presence of coronavirus in the body has received approval from US FDA. FDA has given approval to the ‘InspectIR’ systems which are used to enable the breathalyzer to detect the coronavirus in the human body. The makers claim that the system introduced will give results within three minutes of the test and each day, around 160 samples can be tested by this system, The Times of India reported.

The breathalyzer has the ability to provide results very fast with accuracy in its testing, said the makers. The breathalyzer test was made by Frisco Texas-based InspectIR Systems and is authorized for those 18 and older and in settings where samples are both collected and analyzed. 

The director of the FDA’s centre for Devices and radiological Health said, “ This is one of the rapid innovations occurring in the field of Covid-19 diagnosis. Having plenty of tests to detect the coronavirus will help us with the transition from pandemic to the endemic phase. 

The FDA has given the approval to use the breathalyzer after conducting the test in about 2400 and the results came accurate. In the test, about 91% of the positive samples came correctly, and at the same time, 99% of the negative samples correctly. 

Read Also: Covid-19 is far from settling into an endemic situation: WHO

The FDA said, the device is about the size of a piece of carry-on luggage and works by detecting chemical compounds in breath samples associated with SARS-CoV-2 infection. However, the studies reveal that the breathalyzer’s sensitivity is comparable to that of rapid antigen tests.